C
Curewize
About
Curewize is a leader in the field of personalized medicine, diagnostics and predictive medicine. The Company's goal is to improve the survival rate and overall health outcome of cancer patients. Our proprietary platform technology measures microRNA (miRNA) profiles in patients biofluids. MiRNAs control gene activity, and are considered superior biomarkers for diagnosis and personalized treatment decisions due to their direct link to cancer mechanisms and stability in human biofluid samples. The companys initial product is ProALL, a groundbreaking lab test for deciding on the intensity of treatment of acute lymphoblastic leukemia (ALL) patients.
Technology stack
detected 2026-05-24Est. monthly stack spend~$140/mo
Emailnone
Hosting
AWS
AWSComments
No comments yet. Be the first to share your take.
Frequently asked
What does Curewize do?
Curewize is a leader in the field of personalized medicine, diagnostics and predictive medicine. The Company's goal is to improve the survival rate and overall health outcome of cancer patients. Our proprietary platform technology measures microRNA (miRNA) profiles in patients biofluids. MiRNAs control gene activity, and are considered superior biomarkers for diagnosis and personalized treatment decisions due to their direct link to cancer mechanisms and stability in human biofluid samples. The…
When was Curewize founded?
Curewize was founded in 2012.
What industry does Curewize operate in?
Curewize operates in mRNA, Life Sciences, Biomarkers, Cancer, Personalized.
What is Curewize's current status?
Curewize's current operating status is: Inactive.